退伍军人卫生管理局肺癌生存趋势
Drew Moghanaki1, James Taylor2, Alex K Bryant3
1Veterans Affairs Greater Los Angeles Healthcare System, Radiation Oncology Service, Los Angeles, CA; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.
Clinical lung cancer
|March 29, 2024
概括
退伍军人健康管理局 (VHA) 的退伍军人肺癌生存率正在改善. 与白人退伍军人相比,黑人退伍军人经历了类似或更好的生存率,这表明在结果中存在种族平等.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在美国,肺癌的生存率正在上升.
- 退伍军人卫生管理局 (VHA) 是美国最大的综合医疗保健系统.
研究的目的:
- 调查VHA内的肺癌生存趋势.
- 评估肺癌不同阶段和组织学的生存趋势.
- 为了比较VHA人口中的种族群体之间的生存结果.
主要方法:
- 对退伍军人事务中央癌症登记处数据的分析.
- 用Kaplan-Meier估计和线性回归来进行时间趋势分析.
- 包括54,922名在2010年至2017年期间被诊断患有肺癌的退伍军人.
主要成果:
- 肺癌所有阶段 (I-IV) 的整体存活率 (OS) 改善.
- 非小细胞肺癌 (NSCLC) 的中位 OS 从12个月增加到21个月.
- 小细胞肺癌 (SCLC) 显示3年后的生存率有所改善,尽管中位数的生存率没有变化.
- 患有NSCLC的黑人退伍军人有相似的生存率,而SCLC的退伍军人与白人退伍军人相比,他们的生存率更高.
结论:
- 肺癌存活率在VHA中有所改善.
- 观察到肺癌结果的种族平等,黑人退伍军人表现出类似或更好的生存率.
- 需要进一步的研究,以了解和复制VHA在癌症治疗中实现种族平等的成功.
更多相关视频
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181


